Skip to main content
. 2020 Dec 16;37(4):e2020009. doi: 10.36141/svdld.v37i4.10726

Table 2.

Rate of COVID-19 infection for five questionnaires and total

UC/AMC FSR Dutch Italy Spain Total
Total number Sarcoidosis patients 1972 1616 996 511 105 5200
Number COVID positive 66 13 23 9 5 116
Rate of COVID 3.35% 0.80% 2.31% 1.76% 4.76% 2.23%
Percent COVID-19 based on gender
Male 3.70% 0.72% 1.42% 1.44% 3.57% 2.18%
Female 3.24% 1.59% 2.98% 1.68% 5.19% 2.81%
Percent COVID-19 based on race
Black 2.88% 3.23% NA NA NA 2.95%
White 3.62% 1.15% 2.31% 1.83% 4.90% 2.66%
Mean age of patients with or without COVID-19 infection
Age COVID-19 positive, years 54.5 + 11.39* 54.4 + 11.29 55.3 ± 6.0 55.8+ 8.63 49.80 + 9.20 53.5 + 9.47
Age, COVID-19 Negative, years 53.0 + 9.60 56.6 + 10.39 55.0±10.8 51.8 + 9.74 44.88 + 8.82 52.4 + 9.90
Percent COVID-19 infected versus current prednisone therapy
Yes 3.08% 1.55% 2.02% 0.38% 4.76% 2.68%
No 3.52% 0.62% 2.38% 3.00% 4.76% 2.08%
Percent COVID-19 based on living with COVID-19 infected roommate
Roommate COVID positive 55.3% 40.0% 26.8% 62.5% 0.0% 52.7%
No roommate with COVID 2.33% 0.68% 1.26% 0.80% 4.95% 1.53%
Percent COVID-19 based on occupation as health care provider
Health care provider 5.74% 1.20% 3.88% 4.26% 18.75% 5.46%
Not health care provider 3.09% 0.78% 2.13% 1.52% 2.33% 2.82%

NA: not analyzed because less than 10 patients who were this race

*Mean ± standard deviation